Comparativein vitrocytotoxicity of cyclo
โ
David S. Alberts; Janine G. Einspahr; Robert Struck; Gary Bignami; Laurie Young;
๐
Article
๐
1984
๐
Springer US
๐
English
โ 623 KB
Cyclophosphamide (CPA), the most commonly used alkylating agent in the treatment of a wide variety of hematologic and solid tumors, requires oxidation by hepatic microsomal enzymes to its active alkylating species. A number of alternative methods exist to simulate the in vitro cytotoxicity of CPA ag